# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Silo Pharma, Inc. (NASDAQ: SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company foc...
SPC-14 shows cognitive and stress reduction benefits in preclinical models SARASOTA, FL, April 10, 2024 (GLOBE NEWSWIRE) -- Si...
The Dow Jones index closed lower by around 10 points on Monday. When insiders purchase or sell shares, it indicates their confi...
- SEC Filing
The Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confid...